Squarepoint’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-317
Closed -$22.7K 3935
2022
Q4
$22.7K Sell
317
-2,861
-90% -$271K ﹤0.01% 3099
2022
Q3
$375K Buy
3,178
+732
+30% +$130K ﹤0.01% 2356
2022
Q2
$446K Buy
2,446
+1,355
+124% +$246K ﹤0.01% 2067
2022
Q1
$256K Sell
1,091
-3,363
-76% -$679K ﹤0.01% 2369
2021
Q4
$1.52M Buy
+4,454
New +$2.45M ﹤0.01% 1424
2021
Q2
Sell
-843
Closed -$1.27M 3801
2021
Q1
$1.27M Buy
+843
New +$1.37M 0.01% 1337

Other funds holding DNMR

Squarepoint's DNMR Position: Q1 2023 in Review

Squarepoint sold out of Danimer Scientific, Inc. (DNMR) in Q1 2023, closing a stake of 317 shares — an estimated $22.7K sold.

Squarepoint first reported a position in DNMR in Q1 2021 and held it in 6 quarters. The position peaked at $1.52M in Q4 2021. 160 funds tracked by Wall St. Rank hold DNMR as of Q1 2023.

  • Squarepoint reported no remaining Danimer Scientific, Inc. position as of Q1 2023 after selling out during the quarter.
  • Squarepoint sold 317 Danimer Scientific, Inc. shares in Q1 2023, an estimated $22.7K.
  • Squarepoint first reported a position in Danimer Scientific, Inc. in Q1 2021 and held it in 6 quarters.
  • Squarepoint's Danimer Scientific, Inc. position peaked at $1.52M in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.